These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9156649)

  • 1. Effects of CD40 stimulation in the prevention of human EBV-lymphomagenesis.
    Funakoshi S; Taub DD; Asai O; Hirano A; Ruscetti FW; Longo DL; Murphy WJ
    Leuk Lymphoma; 1997 Jan; 24(3-4):187-99. PubMed ID: 9156649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and prevention.
    Funakoshi S; Beckwith M; Fanslow W; Longo DL; Murphy WJ
    Pathobiology; 1995; 63(3):133-42. PubMed ID: 8821629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.
    Murphy WJ; Funakoshi S; Beckwith M; Rushing SE; Conley DK; Armitage RJ; Fanslow WC; Rager HC; Taub DD; Ruscetti FW
    Blood; 1995 Sep; 86(5):1946-53. PubMed ID: 7544649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human B-cell lymphoma growth by CD40 stimulation.
    Funakoshi S; Longo DL; Beckwith M; Conley DK; Tsarfaty G; Tsarfaty I; Armitage RJ; Fanslow WC; Spriggs MK; Murphy WJ
    Blood; 1994 May; 83(10):2787-94. PubMed ID: 7514045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas.
    Funakoshi S; Longo DL; Murphy WJ
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):93-101. PubMed ID: 8732692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive immunotherapy for Epstein-Barr virus-related lymphoma.
    Smith CA; Ng CY; Loftin SK; Li C; Heslop HE; Brenner MK; Rooney CM
    Leuk Lymphoma; 1996 Oct; 23(3-4):213-20. PubMed ID: 9031101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax.
    Szocinski JL; Khaled AR; Hixon J; Halverson D; Funakoshi S; Fanslow WC; Boyd A; Taub DD; Durum SK; Siegall CB; Longo DL; Murphy WJ
    Blood; 2002 Jul; 100(1):217-23. PubMed ID: 12070030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-->mouse radiation chimera do not develop Epstein-Barr virus lymphoma.
    Marcus H; Burakova T; Shezen E; David M; Canaan A; Lubin I; Reisner Y
    Immunol Lett; 1996 Mar; 49(3):155-61. PubMed ID: 8739310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
    O'Reilly RJ; Lacerda JF; Lucas KG; Rosenfield NS; Small TN; Papadopoulos EB
    Important Adv Oncol; 1996; ():149-66. PubMed ID: 8791134
    [No Abstract]   [Full Text] [Related]  

  • 10. T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody.
    Tutt AL; O'Brien L; Hussain A; Crowther GR; French RR; Glennie MJ
    J Immunol; 2002 Mar; 168(6):2720-8. PubMed ID: 11884438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
    Law CL; Gordon KA; Collier J; Klussman K; McEarchern JA; Cerveny CG; Mixan BJ; Lee WP; Lin Z; Valdez P; Wahl AF; Grewal IS
    Cancer Res; 2005 Sep; 65(18):8331-8. PubMed ID: 16166310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
    Tanner JE; Alfieri C
    Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.
    Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A
    Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
    Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
    J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High CD40 membrane expression in AIDS-related lymphoma B cell lines is associated with the CD45RA+, CD45RO+, CD95+ phenotype and high levels of its soluble form in culture supernatants.
    De Paoli P; Cozzi M; Tedeschi R; Gloghini A; Cilia AM; van Kooten C; Gaidano G; Carbone A
    Cytometry; 1997 Feb; 30(1):33-8. PubMed ID: 9056740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
    Wykes M; Poudrier J; Lindstedt R; Gray D
    Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of CD40 stimulation on normal and neoplastic cell growth.
    Ziebold JL; Hixon J; Boyd A; Murphy WJ
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):225-33. PubMed ID: 11059638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40.
    Willer DO; Speck SH
    J Virol; 2005 Mar; 79(5):2891-9. PubMed ID: 15709008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.